Search Within

Jaap Jan Boelens

  1. "Survivorship Research"
Formats
  1. Journal Article (6)
  2. Meeting Abstract (5)
Groups
  1. Center for Hematologic Malignancies (11)
  2. Pediatrics, Department of (11)
  3. Stem Cell Transplantation and Cellular Therapy Service (11)
  4. Survivorship Research (11)
  5. Tow Center for Developmental Oncology (TCDO) (11)
  6. Bone Marrow Transplant (10)

More Groups

People
  1. Sergio Giralt (10)
  2. Michael Scordo (9)
  3. Miguel-Angel Perales (9)
  4. Ann Jakubowski (8)
  5. Gunjan Shah (8)
  6. Roni Tamari (8)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (1)
  4. 2022 (4)
  5. 2020 (3)
  6. 2019 (1)
Publications
  1. Blood Advances (3)
  2. Bone Marrow Transplantation (3)
  3. Biology of Blood and Marrow Transplantation (2)
  4. Blood (1)
  5. Clinical Pharmacokinetics (1)
  6. Transplantation and Cellular Therapy (1)
Publishers
  1. American Society of Hematology (4)
  2. Elsevier Inc. (3)
  3. Nature Publishing Group (3)
  4. Adis International Ltd (1)

Results (11)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Allogeneic off-the-shelf CAR T-cell therapy for relapsed or refractory B-cell malignancies
    Journal Article

    Shahid, S.; Prockop, S. E.; Flynn, G. C.; Mauguen, A.; White, C. O.; Bieler, J.; McAvoy, D.; Hosszu, K.; Cancio, M. I.; Jakubowski, A. A.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Phase II study of pharmacokinetic model-based ATG dosing to improve survival through enhanced immune reconstitution in patients undergoing ex vivo CD34-selected allogeneic HCT (PRAISE-IR)
    Meeting Abstract

    Scordo, M.; Perales, M. A.; Mauguen, A.; Lin, A.; Kunvarjee, B.; Bieler, J.; Nguyen, L. K.; Paes Pena, M.; Cho, C.; Gyurkocza, B.; more...
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • Association between busulfan exposure and survival in patients undergoing a CD34(+) selected stem cell transplantation
    Journal Article

    Tamari, R.; Scordo, M.; Kunvarjee, B. M.; Proli, A.; Lin, A.; Flynn, J.; Cho, C.; Devlin, S.; Klein, E.; Boulad, F.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • CD19-specific CAR-T cells for the treatment of CNS chloromas in children with relapsed/refractory B-cell acute lymphoblastic leukemia
    Meeting Abstract

    Shahid, S.; Cancio, M.; Haque, S. S.; Khakoo, Y.; McWilliams, E.; Santomasso, B. D.; Scaradavou, A.; Spitzer, B.; Wolden, S. L.; Boelens, J. J.; more...
    Bone Marrow Transplantation (2022)

    Fulltext@MSK | Save
  • Evaluation of melphalan exposure in lymphoma patients undergoing BEAM and autologous hematopoietic cell transplantation
    Journal Article

    Dahi, P. B.; Lin, A.; Scordo, M.; Flynn, J. R.; Devlin, S. M.; Ruiz, J. D.; DeRespiris, L.; Carlow, D.; Cho, C.; Lahoud, O. B.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Population pharmacokinetics of melphalan in a large cohort of autologous and allogeneic hematopoietic cell transplantation recipients: Towards individualized dosing regimens
    Journal Article

    Shah, G. L.; Boelens, J. J.; Carlow, D.; Lin, A.; Schofield, R.; Cruz Sitner, N.; Alperovich, A.; Ruiz, J.; Proli, A.; Dahi, P.; more...
    Clinical Pharmacokinetics (2022)

    Fulltext@MSK | Save
  • Antithymocyte globulin exposure in CD34(+) T-cell–depleted allogeneic hematopoietic cell transplantation
    Journal Article

    Lakkaraja, M.; Scordo, M.; Mauguen, A.; Cho, C.; Devlin, S.; Ruiz, J. D.; Klein, E.; Avecilla, S. T.; Boulad, F.; Cancio, M. I.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Rabbit anti-thymocyte globulin exposure (rATG) in CD34+ selected hematopoietic cell transplantation and its impact on immune reconstitution and outcomes in children and adults
    Meeting Abstract

    Lakkaraja, M.; Scordo, M.; Mauguen, A.; Cho, C.; Devlin, S.; Avecilla, S. T.; Boulad, F.; Cancio, M. I.; Curran, K. J.; Jakubowski, A. A.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Population pharmacokinetic estimation of ATG exposure predicts immune reconstitution and survival in adults undergoing ex vivo CD34-selected allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Scordo, M.; Cho, C.; Devlin, S. M.; Maloy, M. A.; Ruiz, J. D.; Bhatt, V.; Smith, M.; O'Reilly, R. J.; Papadopoulos, E. B.; Jakubowski, A. A.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Population pharmacokinetic model demonstrates poor outcomes with ATG overexposure in adults undergoing ex vivo CD34-selected allogeneic hematopoietic cell
    Meeting Abstract

    Scordo, M.; Cho, C.; Devlin, S. M.; Maloy, M. A.; Ruiz, J. D.; Bhatt, V.; Smith, M.; Shah, G. L.; O'Reilly, R. J.; Papadopoulos, E. B.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save